Global Fertility Services Market Segmentation, By Type (Diagnosis, Treatment, and Preservation), Procedure (Assisted Reproductive Technology (ART), In-Vitro Fertilization, Artificial Insemination, Surrogacy, and Others), Services (Donor and Non-donor), End-User (Fertility Clinics, Hospitals, Clinical Research Institutes, and Surgical Centers) – Industry Trends and Forecast to 2031
Fertility Services Market Analysis
The fertility services market is witnessing robust growth, driven by a combination of increasing infertility rates, advancements in assisted reproductive technologies (ART), and rising awareness about reproductive health. Notable developments in this sector include the integration of cutting-edge technologies, such as preimplantation genetic testing (PGT), which allows for the screening of embryos for genetic disorders, thus improving the success rates of in vitro fertilization (IVF). In addition, the market has seen a rise in telemedicine services, enabling patients to access fertility consultations and treatments from the comfort of their homes. The increasing acceptance of fertility preservation methods, particularly among younger women who wish to delay childbirth, is also shaping the market landscape. Moreover, collaborations between fertility clinics and biotechnology firms are fostering innovation in fertility treatments, leading to personalized solutions tailored to individual needs. With these developments, the fertility services market is poised for continued growth, addressing the evolving demands of patients and enhancing the overall reproductive health ecosystem.
Fertility Services Market Size
The global fertility services market size was valued at USD 20.24 billion in 2023 and is projected to reach USD 36.63 billion by 2031, with a CAGR of 7.70% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Fertility Services Market Trends
“Growing Demand for Fertility Preservation”
The fertility services market is experiencing significant growth due to rising infertility rates and increasing awareness of reproductive health. In particular, assisted reproductive technologies (ART) such as in vitro fertilization (IVF) have gained popularity as effective solutions for couples struggling to conceive. A notable trend in the market is the growing demand for fertility preservation, particularly among women delaying childbirth for career or personal reasons. For instance, many clinics now offer egg freezing services to help women maintain their reproductive options. In addition, advancements in genetic testing and embryo selection technologies are enhancing success rates, making ART more appealing. As a result, the fertility services market is projected to expand further, with increased investment in innovative solutions that cater to diverse patient needs. This growth reflects a broader societal shift towards prioritizing reproductive health and providing individuals with the tools and support they need to build families.
Report Scope and Fertility Services Market Segmentation
|
Attributes
|
Fertility Services Key Market Insights
|
|
Segments Covered
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
Olympus Corporation (Japan), The Cooper Companies Inc. (U.S.), Instituto Bernabeu (Spain), VirtusHealth (Australia), CooperSurgical, Inc. (U.S.), Vitrolife (Sweden), Care Fertility (U.K.), INVO Bioscience (U.S.), Monash IVF (Australia), Fertility Focus Limited (U.S.), Carolinas Fertility Institute (U.S.), Apollo Hospitals Group (India), Merck KGaA (Germany), LABOTECT GMBH (Germany), and Medicover AB (Sweden)
|
|
Market Opportunities
|
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Fertility Services Market Definition
Fertility services refer to a comprehensive range of medical treatments and interventions designed to assist individuals and couples in achieving pregnancy. These services include diagnostic testing to identify fertility issues, assisted reproductive technologies (ART) such as in vitro fertilization (IVF) services and intrauterine insemination (IUI), as well as fertility preservation techniques such as egg or sperm freezing. In addition, fertility services often provide counseling and support to help individuals navigate the emotional challenges associated with infertility, ultimately aiming to enhance reproductive health and facilitate family planning.
Fertility Services Market Dynamics
Drivers
- Rising Infertility Rates
Rising infertility rates among couples are a significant driver of demand for fertility services, influenced by factors such as delayed marriage, lifestyle choices, and environmental factors. According to the World Health Organization (WHO), approximately 15% of couples globally experience infertility, with the prevalence rising due to changing societal norms, where individuals often prioritize education and career before starting families. In addition, lifestyle factors, such as unhealthy diets, increased stress levels, and rising obesity rates, further contribute to fertility challenges. For instance, the American Society for Reproductive Medicine (ASRM) reports that conditions such as polycystic ovary syndrome (PCOS) and male infertility are becoming more common, exacerbating the need for assisted reproductive technologies. As couples face these challenges, the demand for fertility services continues to grow, driving innovations and expansions in the market.
- Growing Market for Egg Freezing
The growing market for egg freezing is a significant driver in the fertility services sector, reflecting changing societal norms and increasing awareness among women about their reproductive options. According to the American Society for Reproductive Medicine (ASRM), egg freezing cycles increased to 29,803, up from 24,560 in 2021. Additionally, advancements in freezing technologies, such as vitrification, have significantly improved the success rates of thawing frozen eggs, further encouraging women to consider this option. As more fertility clinics offer egg freezing services and provide educational resources, this growing awareness is likely to drive demand, making egg freezing a key component of the fertility services market, thereby driving the market growth.
Opportunities
- Increasing Awareness Regarding In Vitro Fertilization (IVF)
The increase in awareness regarding in vitro fertilization (IVF) is creating significant opportunities within the global fertility services market. As more individuals and couples become informed about the benefits of IVF, particularly in addressing infertility challenges, the demand for these services has surged. Educational initiatives, social media campaigns, and success stories shared by patients are helping to demystify the IVF process and reduce stigma surrounding fertility treatments. For instance, organizations such as the American Society for Reproductive Medicine (ASRM) provide resources and information that empower couples to make informed decisions about their reproductive health. Additionally, the rise of fertility clinics offering comprehensive services, such as egg freezing and fertility preservation, caters to the evolving needs of patients, especially those delaying parenthood for personal or professional reasons. This heightened awareness and acceptance of IVF, combined with advancements in reproductive technologies, is expected to drive significant growth in the global fertility services market, creating new opportunities for service providers and innovators in the field.
- Increasing Advancements in Genetic Testing
Advancements in technology are revolutionizing the fertility services market, particularly through innovations in assisted reproductive technologies (ART) that enhance success rates and attract a growing patient base. For instance, Advancements in genetic testing, such as preimplantation genetic testing for aneuploidy (PGT-A), allow for the screening of embryos for chromosomal abnormalities before implantation, further increasing the likelihood of successful pregnancies. As these technologies become more widely adopted, fertility clinics that integrate them into their practice can significantly improve patient outcomes and satisfaction, thus positioning themselves competitively in a rapidly evolving market. This technological evolution fosters patient trust and opens new opportunities for clinics focused on providing cutting-edge fertility solutions.
Restraints/Challenges
- High Treatment Costs
High treatment costs present a substantial challenge in the fertility services market, as the expenses associated with procedures such as In-Vitro Fertilization (IVF) and other assisted reproductive technologies can be prohibitively high for many patients. The financial burden can lead to significant stress for couples trying to conceive, especially since multiple treatment cycles are often needed for success. Furthermore, many insurance plans do not cover fertility treatments, limiting access for a considerable portion of the population. This lack of coverage disproportionately affects low- and middle-income individuals, who may be forced to make difficult decisions regarding their reproductive health. As a result, high treatment costs hinder access to essential medical care and contribute to growing disparities in reproductive health outcomes.
- Ethical Concerns Surrounding Assisted Reproductive Technologies
Ethical concerns surrounding assisted reproductive technologies (ART) represent a significant challenge in the fertility services market, as they encompass various implications related to genetic testing, embryo selection, and the use of donor gametes. For instance, the practice of embryo selection, which involves choosing embryos with the highest likelihood of successful implantation based on genetic profiling, raises questions about "designer babies" and the moral implications of selecting traits. These ethical dilemmas can create hesitancy among potential patients, as individuals may grapple with the moral considerations of their choices regarding reproduction. In addition, public backlash can arise against certain practices, leading to increased scrutiny and potential regulatory restrictions on ART. Such ethical complexities can deter individuals from seeking fertility treatments, ultimately impacting market growth and the willingness of healthcare providers to offer certain services, thereby presenting a notable challenge within the fertility services sector.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Fertility Services Market Scope
The market is segmented on the basis of infertility, procedure, services, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Diagnosis
- Male infertility
- DNA Fragmentation Technique
- Oxidative Stress Analysis
- Microscopic Examination
- Sperm Agglutination
- Computer Assisted Semen Analysis
- Sperm Penetration Assay
- Others
- Female infertility
- Ovarian reserve testing
- Hysterosalpingography
- Hormone testing
- Other Tests
- Treatment
- In-Vitro Fertilization (IVF)
- Artificial Insemination
- Preservation
- Egg & Embryo Freezing
- Sperm Banking
Procedure
- Assisted Reproductive Technology (ART)
- In-Vitro Fertilization (IVF)
- Artificial Insemination
- Surrogacy
- Others
Services
- Donor services
- Non-donor services
End-User
- Fertility clinics
- Hospitals
- Clinical research institutes
- Surgical centers
Fertility Services Market Regional Analysis
The market is analysed and market size insights and trends are provided by country, infertility, procedure, services, and end-user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America leads the fertility services market, driven by several key factors, including declining fertility rates and a rising median age of motherhood. As more women delay childbirth for various reasons, the demand for fertility services has increased significantly. In addition, the growing prevalence of obesity in the region further contributes to fertility challenges, prompting individuals and couples to seek assisted reproductive technologies and related services to enhance their chances of conception.
Asia-Pacific region is projected to experience the highest growth rate from 2022 to 2029, driven primarily by a notable decline in fertility rates. This trend not only impacts demographic dynamics but also influences healthcare demand and resource allocation. As a result, the region's healthcare sector is expected to adapt to changing population needs and preferences, fostering innovation and investment opportunities.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Fertility Services Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Fertility Services Market Leaders Operating in the Market Are:
- Olympus Corporation (Japan)
- The Cooper Companies Inc. (U.S.)
- Instituto Bernabeu (Spain)
- VirtusHealth (Australia)
- CooperSurgical, Inc. (U.S.)
- Vitrolife (Sweden)
- Care Fertility (U.K.)
- INVO Bioscience (U.S.)
- Monash IVF (Australia)
- Fertility Focus Limited (U.S.)
- Carolinas Fertility Institute (U.S.)
- Apollo Hospitals Enterprise Ltd. (India)
- Merck KGaA (Germany)
- LABOTECT GMBH (Germany)
- Medicover AB (Sweden)
Latest Developments in Fertility Services Market
- In June 2023, Quantum Health formed a partnership with Progyny, Inc. to launch Quantum Health's Comprehensive Care Solutions platform, specifically designed to provide family building and fertility solutions. This collaboration aims to enhance access to fertility services, offering a streamlined approach to care that supports individuals and couples on their journey to parenthood
- In April 2023, Cryoport, Inc. entered into a three-year supply chain agreement with Boston IVF to facilitate the shipment of reproductive materials across the United States. This partnership is intended to ensure the safe and timely transport of critical biological samples, such as eggs, sperm, and embryos, which are essential for fertility treatments
- In October 2022, Maven Clinic, a U.S.-based company specializing in telemedicine and virtual clinic services for women’s and family health, partnered with Indira IVF, an India-based infertility specialty clinic chain. This collaboration aims to extend access to Indira IVF's high-quality clinical care to Maven's members in India, enhancing the support available for family-building needs
- In July 2021, Hamilton Throne Ltd., a global provider of ART research, acquired IVFTECH ApS (IVFtech) and its affiliated company, K4 Technology ApS. This acquisition strengthens IVFtech's commitment to providing laminar flow workstations and large-capacity incubators for assisted reproductive technology (ART), leveraging the resources and expertise of K4 Technology. Together, they aim to enhance the quality and efficiency of ART solutions in the industry
- In May 2021, Virtus Health, a global leader in Assisted Reproductive Services (ARS), announced a strategic partnership with Drop Bio, an Australian biotechnology and digital health firm specializing in chronic inflammation. This collaboration aims to enhance advancements in precision fertility, leveraging both companies' expertise to improve fertility outcomes and tailor treatments to individual patient needs
- In June 2020, Ferring B.V. and Igenomix established a four-year research collaboration focused on developing innovative therapeutic products for the treatment of pregnancy-related conditions. This partnership combines Ferring's expertise in reproductive medicine with Igenomix's cutting-edge genetic analysis capabilities
SKU-